Gene id |
100132285 |
Gene Summary Protein Summary Gene ontology KEGG pathways Diseases PubMed |
Gene Summary
|
Gene Symbol |
KIR2DS2 Gene UCSC Ensembl |
Aliases |
183ActI, CD158J, CD158b, KIR-2DS2, NKAT-5, NKAT5, cl-49 |
Gene name |
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 2 |
Alternate names |
killer cell immunoglobulin-like receptor 2DS2, CD158 antigen-like family member J, MHC class I NK cell receptor, NK receptor 183 ActI, killer cell immunoglobulin-like receptor KIR2DS2, killer cell immunoglobulin-like receptor, two domains, short cytoplasm, |
Gene location |
19q13.4 (: ) Exons:
|
Gene summary(Entrez) |
Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the
|
OMIM |
604953 |
Protein Summary
|
Protein general information
| P43631
Name: Killer cell immunoglobulin like receptor 2DS2 (CD158 antigen like family member J) (MHC class I NK cell receptor) (NK receptor 183 ActI) (Natural killer associated transcript 5) (NKAT 5) (p58 natural killer cell receptor clone CL 49) (p58 NK receptor CL 4
Length: 304 Mass: 33,502
|
Sequence |
MSLMVVSMACVGFFLLQGAWPHEGVHRKPSLLAHPGPLVKSEETVILQCWSDVRFEHFLLHREGKYKDTLHLIGE HHDGVSKANFSIGPMMQDLAGTYRCYGSVTHSPYQLSAPSDPLDIVITGLYEKPSLSAQPGPTVLAGESVTLSCS SRSSYDMYHLSREGEAHERRFSAGPKVNGTFQADFPLGPATHGGTYRCFGSFRDSPYEWSNSSDPLLVSVTGNPS NSWPSPTEPSSKTGNPRHLHVLIGTSVVKIPFTILLFFLLHRWCSNKKNAAVMDQEPAGNRTVNSEDSDEQDHQE VSYA
|
Structural information |
|
Other Databases |
GeneCards: KIR2DS2  Malacards: KIR2DS2 |
|
GO accession | Term name | Evidence code | Go category |
---|
GO:0004888 |
transmembrane signaling r eceptor activity
|
NAS |
molecular function |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0006955 |
immune response
|
NAS |
biological process |
GO:0007165 |
signal transduction
|
IEA |
biological process |
GO:0016021 |
integral component of mem brane
|
NAS |
cellular component |
GO:0045087 |
innate immune response
|
TAS |
biological process |
GO:0050776 |
regulation of immune resp onse
|
TAS |
biological process |
GO:0004888 |
transmembrane signaling r eceptor activity
|
NAS |
molecular function |
GO:0005886 |
plasma membrane
|
IEA |
cellular component |
GO:0005886 |
plasma membrane
|
IEA |
cellular component |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0006955 |
immune response
|
NAS |
biological process |
GO:0007165 |
signal transduction
|
IEA |
biological process |
GO:0016020 |
membrane
|
IEA |
cellular component |
GO:0016021 |
integral component of mem brane
|
IEA |
cellular component |
GO:0016021 |
integral component of mem brane
|
NAS |
cellular component |
GO:0045087 |
innate immune response
|
TAS |
biological process |
GO:0050776 |
regulation of immune resp onse
|
TAS |
biological process |
GO:0004888 |
transmembrane signaling r eceptor activity
|
NAS |
molecular function |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0005886 |
plasma membrane
|
TAS |
cellular component |
GO:0006955 |
immune response
|
NAS |
biological process |
GO:0016021 |
integral component of mem brane
|
NAS |
cellular component |
GO:0045087 |
innate immune response
|
TAS |
biological process |
GO:0050776 |
regulation of immune resp onse
|
TAS |
biological process |
|
|
Pathway id | Pathway name |
hsa00480 | Glutathione metabolism | hsa00512 | Mucin type O-glycan biosynthesis | hsa04650 | Natural killer cell mediated cytotoxicity | hsa04612 | Antigen processing and presentation | |
|
Associated diseases |
References |
Cancer (Hepatocellular) | GAD: 19326408 |
Cancer (leukemia) | GAD: 19450876 |
Cancer (lymphoma) | GAD: 20207982 |
Cancer (Neuroblastoma) | GAD: 19934297 |
Cardiovascular disease | GAD: 18755860 |
Graves disease | GAD: 19664392 |
Chorioretinitis | GAD: 18340360 |
Arthritis | GAD: 17882223 |
Behcet's disease | GAD: 17868255 |
Ulcerative colitis | GAD: 16929347 |
Rheumatoid arthritis | GAD: 11369787 |
Multiple sclerosis | GAD: 19421224 |
Scleroderma | GAD: 20082621 |
Psoriasis | GAD: 18681957 |
Psoriatic arthritis | GAD: 16112031 |
Systemic lupus erythematosus (SLE) | GAD: 17445179 |
Systemic lupus erythematosus (SLE) | GAD: 18687225 |
Autoimmune diseases | GAD: 20082482 |
Axial spondyloarthropathy | GAD: 19850842 |
Diabetes | GAD: 14514651 |
Osteoarthritis | GAD: 19489269 |
Osteoarthritis | GAD: 19489269 |
Ankylosing spondylitis | GAD: 19019897 |
Paraparesis | GAD: 20483367 |
Uveomeningoencephalitic syndrome | GAD: 18571006 |
Vogt-Koyanagi-Harada syndrome | GAD: 19897003 |
Abortion | GAD: 20210919 |
Pregnancy loss | GAD: 19279038 |
Spontaneous abortion | GAD: 19875891 |
Cryptorchidism | MIK: 26679162 |
Cryptorchidism | MIK: 26679162 |
|
|
PMID |
Condition |
Mutation |
Ethnicity |
Population details |
Infertility_type |
Associated_genes |
Abstract |
26679162 |
Cryptorchi dism
|
|
|
245 (109 prepub ertal boys with cryptorchidism , 136 ethnicall y matched young male donors)
|
Male infertility |
|
Show abstract |
|